401k Record

Employers › Bionano Genomics

Bionano Genomics 401(k)

Recordkeeping fees per participant · Bionano Genomics, Inc. 401(k) Plan · plan year 2024

$24.78

Higher than 23% of the 14,075 plans $10 to 50M that report it.

Source

= $10,062 / 406
Schedule H, line 2i(3); OTH_RECORDKEEPING_FEES_AMT pos 160; filing 20250919050221NAL0004679042001, received 2025-09-19
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20250919050221NAL0004679042001, received 2025-09-19

10th: $10.53median $83.9490th: $217.08

Percentiles compare this plan with the Schedule H plans $10 to 50M in assets of the same plan year, excluding final filings; shown only where at least 50 comparable plans report the figure. Plan year 2024-01-01 to 2024-12-31, filing received 2025-09-19.

Cost and contributions

Administrative expenses excluding investment management, per participant

$24.78

10th: $15.36median $118.8890th: $340.63

Higher than 16% of the 24,371 plans $10 to 50M that report it.

Source

= $10,062 / 406
derived, admin_expenses (2i(12)) minus invst_mgmt_fees (2i(5)), floored at 0; filing 20250919050221NAL0004679042001, received 2025-09-19
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20250919050221NAL0004679042001, received 2025-09-19

Administrative expenses per participant

$174.51

10th: $26.86median $197.2590th: $456.10

Higher than 45% of the 25,098 plans $10 to 50M that report it.

Source

= $70,852 / 406
Schedule H, line 2i(12) total administrative expenses; TOT_ADMIN_EXPENSES_AMT pos 109; filing 20250919050221NAL0004679042001, received 2025-09-19
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20250919050221NAL0004679042001, received 2025-09-19

Administrative expenses as a share of assets

0.249%

10th: 0.035%median 0.289%90th: 0.599%

Higher than 43% of the 25,132 plans $10 to 50M that report it.

Source

= $70,852 / $28,442,572
Schedule H, line 2i(12) total administrative expenses; TOT_ADMIN_EXPENSES_AMT pos 109; filing 20250919050221NAL0004679042001, received 2025-09-19
assets_eoy: Schedule H, Part I line 1f col (b); TOT_ASSETS_EOY_AMT pos 61; filing 20250919050221NAL0004679042001, received 2025-09-19

Employer contributions per participant

$2,851

10th: $664median $2,07490th: $4,751

Higher than 70% of the 24,050 plans $10 to 50M that report it.

Source

= $1,157,375 / 406
Schedule H, Part II line 2a(1)(A); EMPLR_CONTRIB_INCOME_AMT pos 68; filing 20250919050221NAL0004679042001, received 2025-09-19
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20250919050221NAL0004679042001, received 2025-09-19

Employer share of total contributions

30.1%

10th: 13.1%median 27.9%90th: 45.2%

Higher than 58% of the 24,084 plans $10 to 50M that report it.

Source

= $1,157,375 / $3,849,003
Schedule H, Part II line 2a(1)(A); EMPLR_CONTRIB_INCOME_AMT pos 68; filing 20250919050221NAL0004679042001, received 2025-09-19
total_contrib: Schedule H, line 2a(3); TOT_CONTRIB_AMT pos 72; filing 20250919050221NAL0004679042001, received 2025-09-19

Plan terms, as stated in Bionano Genomics, Inc.'s SEC filings

Plan terms are described in Bionano Genomics, Inc.'s SEC filings: Form 10-K filed 2026-03-23. No term could be quoted from them with the required precision.

Plan features

2E profit-sharing · 2F ERISA 404(c) plan · 2G fully participant-directed · 2J 401(k) feature · 2K 401(m) arrangement · 2S pre-approved plan document · 2T default investment (QDIA) · 3D IRS pre-approved plan · Form 5500, line 8a; TYPE_PENSION_BNFT_CODE pos 81; filing 20250919050221NAL0004679042001, received 2025-09-19

Full record, Bionano Genomics, Inc. 401(k) Plan

FieldValueSource
Plan sponsorBIONANO GENOMICS, INC.Form 5500, Part II line 2a; SPONSOR_DFE_NAME pos 19; filing 20250919050221NAL0004679042001, received 2025-09-19
Plan nameBIONANO GENOMICS, INC. 401(K) PLANForm 5500, line 1a; PLAN_NAME pos 16; filing 20250919050221NAL0004679042001, received 2025-09-19
Sponsor EIN / plan number26-1756290 / 001Form 5500, line 2b; SPONS_DFE_EIN pos 44; filing 20250919050221NAL0004679042001, received 2025-09-19
Plan typesingle-employerForm 5500, Part I line A; TYPE_PLAN_ENTITY_CD pos 4; filing 20250919050221NAL0004679042001, received 2025-09-19
Sponsor locationSAN DIEGO, CAForm 5500, line 2a; SPONS_DFE_MAIL_US_STATE pos 25; filing 20250919050221NAL0004679042001, received 2025-09-19
Industry (business code)541700, Professional, scientific, and technical servicesForm 5500, line 2d; BUSINESS_CODE pos 46; filing 20250919050221NAL0004679042001, received 2025-09-19
Plan year2024-01-01 to 2024-12-31Form 5500, Part I plan year; FORM_PLAN_YEAR_BEGIN_DATE pos 2; filing 20250919050221NAL0004679042001, received 2025-09-19
Filing received2025-09-19Form 5500, EFAST2 receipt date; DATE_RECEIVED pos 102; filing 20250919050221NAL0004679042001, received 2025-09-19
Final filingnoForm 5500, Part I line B; FINAL_FILING_IND pos 8; filing 20250919050221NAL0004679042001, received 2025-09-19
Amended filingnoForm 5500, Part I line B; AMENDED_IND pos 7; filing 20250919050221NAL0004679042001, received 2025-09-19
Participants, beginning of year493Form 5500, line 5; TOT_PARTCP_BOY_CNT pos 71; filing 20250919050221NAL0004679042001, received 2025-09-19
Active participants79Form 5500, line 6a(2); TOT_ACTIVE_PARTCP_CNT pos 72; filing 20250919050221NAL0004679042001, received 2025-09-19
Participants, end of year409Form 5500, line 6f; TOT_ACT_RTD_SEP_BENEF_CNT pos 77; filing 20250919050221NAL0004679042001, received 2025-09-19
Participants with an account balance406Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20250919050221NAL0004679042001, received 2025-09-19
Total assets, beginning of year$28,617,715Schedule H, Part I line 1f col (a); TOT_ASSETS_BOY_AMT pos 30; filing 20250919050221NAL0004679042001, received 2025-09-19
Total assets, end of year$28,442,572Schedule H, Part I line 1f col (b); TOT_ASSETS_EOY_AMT pos 61; filing 20250919050221NAL0004679042001, received 2025-09-19
Net assets, end of year$28,442,572Schedule H, line 1l col (b); NET_ASSETS_EOY_AMT pos 67; filing 20250919050221NAL0004679042001, received 2025-09-19
Total income$8,237,261Schedule H, Part II line 2d; TOT_INCOME_AMT pos 97; filing 20250919050221NAL0004679042001, received 2025-09-19
Net income$-175,143Schedule H, line 2k; NET_INCOME_AMT pos 111; filing 20250919050221NAL0004679042001, received 2025-09-19
Employer contributions$1,157,375Schedule H, Part II line 2a(1)(A); EMPLR_CONTRIB_INCOME_AMT pos 68; filing 20250919050221NAL0004679042001, received 2025-09-19
Participant contributions$2,582,895Schedule H, line 2a(1)(B); PARTICIPANT_CONTRIB_AMT pos 69; filing 20250919050221NAL0004679042001, received 2025-09-19
Other contributions (incl. rollovers)$108,733Schedule H, line 2a(1)(C); OTH_CONTRIB_RCVD_AMT pos 70; filing 20250919050221NAL0004679042001, received 2025-09-19
Total contributions$3,849,003Schedule H, line 2a(3); TOT_CONTRIB_AMT pos 72; filing 20250919050221NAL0004679042001, received 2025-09-19
Benefit payments$8,251,974Schedule H, line 2e(4); TOT_DISTRIB_BNFT_AMT pos 101; filing 20250919050221NAL0004679042001, received 2025-09-19
Total expenses (incl. benefit payments)$8,412,404Schedule H, line 2j; TOT_EXPENSES_AMT pos 110; filing 20250919050221NAL0004679042001, received 2025-09-19
Total administrative expenses$70,852Schedule H, line 2i(12) total administrative expenses; TOT_ADMIN_EXPENSES_AMT pos 109; filing 20250919050221NAL0004679042001, received 2025-09-19
Recordkeeping fees$10,062Schedule H, line 2i(3); OTH_RECORDKEEPING_FEES_AMT pos 160; filing 20250919050221NAL0004679042001, received 2025-09-19
Investment advisory and management fees$60,790Schedule H, line 2i(5); INVST_MGMT_FEES_AMT pos 107; filing 20250919050221NAL0004679042001, received 2025-09-19
Administrative expenses excluding investment management$10,062derived, admin_expenses (2i(12)) minus invst_mgmt_fees (2i(5)), floored at 0; filing 20250919050221NAL0004679042001, received 2025-09-19
Held in common/collective trusts$1,036,966Schedule H, line 1c(9) col (b); INT_COMMON_TR_EOY_AMT pos 51; filing 20250919050221NAL0004679042001, received 2025-09-19
Held in mutual funds$27,377,569Schedule H, line 1c(13) col (b); INT_REG_INVST_CO_EOY_AMT pos 55; filing 20250919050221NAL0004679042001, received 2025-09-19
Independent auditorCOULTER & JUSTUS, P.C.Schedule H, Part III line 3a; ACCOUNTANT_FIRM_NAME pos 116; filing 20250919050221NAL0004679042001, received 2025-09-19

Position = column in the DOL layout for form year 2024. Filing 20250919050221NAL0004679042001, received 2025-09-19.

Service providers paid directly by the plan

ProviderRelationshipService codesDirect compensationIndirect
MORGAN STANLEY SMITH BARNEYrecordkeeperINVESTMENT/FINANCIAL ADVI 15 Recordkeeping and information management; 21 Trustee (bank, trust company or similar); 49 Other services; 50 Direct payment from the plan; 64 Recordkeeping fees; 99 Other fees $60,789no
ADP, INC.recordkeeperRECORD KEEPER 37 Participant loan processing; 50 Direct payment from the plan; 15 Recordkeeping and information management; 64 Recordkeeping fees $10,061yes
ADP BROKER-DEALERrecordkeeperRECORD KEEPER 60 Sub-transfer agency fees; 59 Shareholder servicing fees $0yes

Schedule C Part I line 2: name (a), service codes (b), relationship (c), direct compensation paid by the plan (d), indirect compensation received (e). Filing 20250919050221NAL0004679042001, received 2025-09-19.

What changed since the 2023 plan year

Figure20232024Change
Total assets$28,617,715$28,442,572-0.6%
Participants with a balance486406-16.5%
Administrative expenses$57,001$70,85224.3%
Recordkeeping fees per participant$13.00$24.7890.7%
Employer contributions$1,797,705$1,157,375-35.6%

Prior filing 20241003054039NAL0004609779001, received 2024-10-03; the plan years are contiguous.

Alerts, claims and corrections

Alert me when this filing changes

One email when a new Form 5500 for Bionano Genomics, Inc. 401(k) Plan appears in the Department of Labor data. Confirmation link first; unsubscribe link in every email.

Claim this plan

For the sponsor or its plan administrator: request to verify or annotate this page. A work email address at the sponsor speeds up verification.

Report a correction

Every figure is reproduced from the filing with its source. Tell us which figure and what the filing says instead.

Sponsor name as filed: BIONANO GENOMICS, INC.; SEC registrant: Bionano Genomics, Inc. (CIK 1411690, matched by EIN; display name from the Form 10-K cover).